Abstract
The density functional theory (DFT) and Tomasi’s polarized continuum model (PCM) were used for the investigation of solvent polarity and its dielectric constant effects on the relative stability and NMR shielding tensors of antidepressant mirtazapine (MIR). The obtained results indicated that the relative stability in the polar solvents is higher than that in non-polar solvents and the most stable structure was observed in the water at the B3LYP/6-311++G (d,p) level of theory. Also, natural bond orbital (NBO) interpretation demonstrated that by increase of solvent dielectric constant, negative charge on nitrogen atoms of heterocycles and resonance energy for LP(N10) → σ* and π* delocalization of the structure’s azepine ring increase and the highest values of them were observed in water. On the other hand, NMR calculations showed that with an increase in negative charge of nitrogen atoms, isotropic chemical shielding (σiso) around them increase and nitrogen of piperazine ring (N19) has the highest values of negative charge and σiso among nitrogen atoms. NMR calculations also represented that direct solvent effect on nitrogen of pyridine ring (N15) is more than other nitrogens, while its effect on N19 is less than other ones. Based on NMR data and NBO interpretation, it can be deduced that with a decrease in the negative charge on nitrogen atoms, the intramolecular effects on them decrease, while direct solvent effect increases.
Similar content being viewed by others
References
P. M. Hartmann, Am. Fam. Phys. 59, 159 (1999).
T. de Boer, J. Clin. Psychiatry 57 (Suppl. 4), 19 (1996).
S. A. Anttila and E. V. Leinonen, CNS Drug Rev. 7, 249 (2001).
T. de Boer, F. Nefkens, and A. van Helvoirt, Eur. J. Pharmacol. 253, R5 (1994).
T. de Boer, G. Maura, M. Raiteri, C. de Vos, J. Wieringa, and R. Pinder, Neuropharmacol. 27, 399 (1988).
K. J. Holm and A. Markham, Drugs 57, 607 (1999).
G. S. Ruigt, B. Kemp, C. M. Groenhout, and H. A. Kamphuisen, Eur. J. Clin. Pharmacol. 38, 551 (1990).
G. L. Stimmel, J. A. Dopheide, and S. M. Stahl, Pharmacotheraphy 17, 10 (1997).
P. Jolliet, G. Veyrac, and M. Bourin, Eur. Psychiatry 16, 503 (2001).
T. Romiguieres, F. Pehourcq, M. Matoga, B. Begaud, and C. Jarry, J. Chromatogr. B 775, 163 (2002).
S. Dodd, G. D. Burrows, and T. R. Norman, J. Chromatogr. B 748, 439 (2000).
U. Selditz, Y. Liao, J. P. Franke, R. A. de Zeeuw, and H. Wikström, J. Chromatogr. A 803, 169 (1998).
C. Kirkton and I. M. McIntyre, J. Anal. Toxicol. 30, 687 (2006).
J. E. Paanakker and H. J. M. van Hal, J. Chromatogr. Biomed. Appl. 417, 203 (1987).
I. Meineke, I. Kress, W. Poser, E. Rüther, and J. Brockmöller, Ther. Drug. Monit. 26, 277 (2004).
N. Karasen and S. Altinöz, J. Pharm Biomed. Anal. 24, 11 (2000).
P. M. Bhatt, N. V. Ravindra, R. Banerjee, and G. R. Desiraju, Chem. Commun. 8, 1073 (2005).
E. Iishi and Y. Imamiya, US Patent No. 6723845 B2, EP 1225174 B1 (2007).
B. Sarma, R. Thakuria, N. K. Nath, and A. Nangia, Cryst. Eng. Commun. 13, 3232 (2011).
J. Kelder, C. Funke, T. de Boer, L. Delbressine, D. Leysen, and V. Nickolson, J. Pharm. Pharmacol. 49, 403 (1997).
S. G. Sagdinc and A. E. Sahinturk, J. Mol. Struct. 1021, 53 (2012).
S. G. Sagdinc and A. E. Sahinturk, Spectrochim. Acta A: Mol. Biomol. Spectrosc. 104, 222 (2013).
H. Demirhan, M. Arslan, M. Zengin, and M. Kucukislamoglu, J. Spectrosc. 2013, 1 (2013).
C. W. Funke, Recl. Trav. Chim. Pays-Bas 101, 437 (1982).
B. Chankvetadze, G. Endresz, D. Bergenthal, and G. Blaschke, J. Chromatogr. A 717, 245 (1995).
A. A. Salari, M. Talebi Tari, M. Noei, and A. Tahan, Arab. J. Chem., Available online August 27, 2013 (in press).
A. Tahan and N. Ahmadinejad, J. Struct. Chem. 55, C877 (2014).
J. B. Foresman, T. A. Keith, K. B. Wiberg, J. Snoonian, and M. J. Frisch, J. Phys. Chem. 100, 16098 (1996).
E. D. Glendening, A. E. Reed, J. E. Carpenter, and F. Reinhold, NBO, Version 3.1 (1998).
A. E. Reed, L. A. Curtiss, and F. Weinhold, Chem. Rev. 88, 899 (1988).
R. Cammi, B. Mennucci, and B. Tomasi, J. Chem. Phys. 110, 7627 (1999).
M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, J. R. Cheeseman, J. A. Montgometry, T. Vreven, K. N. Kudin, J. C. Burant, J. M. Milliam, S. S. Iyengar, J. Jomasi, V. Barone, B. Mennucci, et al., Gaussian 03, Revision A.1 (Gaussian Inc., Pittsburgh, PA, 2003).
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Tahan, A., Khojandi, M. & Salari, A.A. The theoretical investigation of solvent effects on the relative stability and 15N NMR shielding of antidepressant heterocyclic drug. Russ. J. Phys. Chem. 90, 130–135 (2016). https://doi.org/10.1134/S0036024416010039
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0036024416010039